House Lawmaker Raises New Concerns Over FDA’s Ultra-Fast Drug Review Program

(MedPage Today) — A Democratic lawmaker is raising new concerns about an FDA program designed to drastically shorten the review of certain drugs, including whether senior officials involved in the effort are complying with federal ethics rules…